Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin A in Psoriasis Vulgaris
NCT02577185Phase 1Completed
- Sponsor
- LEO Pharma
- Start
- Nov 2015
- Primary completion
- Jul 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised trial in Psoriasis vulgaris (PV) comparing Botulinum Toxin Type A with Vehicle (2 arms). Primary endpoint: Total Clinical Score at 8 weeks. Started Nov 2015; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
Psoriasis vulgaris (PV)
Beyond the preview
Go deeper on NCT02577185.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02577185.